Star Health reported a 3% YoY increase in GWP during 4Q, reaching 8% excluding the new accounting policy. PAT stood at Rs5.1mn, impacted by lower investment income and a higher combined ratio. The company raised prices on six products contributing 60% of GWP. FY28 targets remain unchanged, aiming for Rs300bn GWP and Rs25bn PAT. The stock has a target price of Rs500
Read more at MoneycontrolAd
Ad